Closed-loop optogenetic targeting of PV interneurons in AD restores circuit dysfunction through TREM2-mediated microglial immunometabolic regulation. Analogously, astrocyte-selective APOE4 silencing in neurodegeneration via lipid nanoparticles could be reframed as a TREM2-targeted microglial strategy that leverages the shared neuroinflammation-oxidative stress axis. Specifically, TREM2-activating LNPs administered to microglia in neurodegeneration models should reduce neuroinflammatory markers (
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.55
Evidence
0.45
Novelty
0.65
Feasibility
0.00
Impact
0.00
Druggability
0.00
Safety
0.00
Competition
0.00
Data
0.00
Reproducible
0.00
KG Connect
0.53
Score Breakdown
Dimension
TREM2-Modulating LNPs for Neur
Mechanistic
0.550
Evidence
0.450
Novelty
0.650
Feasibility
0.000
Impact
0.000
Druggability
0.000
Safety
0.000
Competition
0.000
Data
0.000
Reproducible
0.000
KG Connect
0.533
Evidence
TREM2-Modulating LNPs for Neurodegeneration: Cell-Type-Speci